NSB 5.71% 3.7¢ neuroscientific biopharmaceuticals ltd

Ann: Investor Update Webinar, page-39

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 442 Posts.
    lightbulb Created with Sketch. 122
    I tried to catch the knife today at 0.09. The shares are in free fall.

    why would HREC approve an early phase trial in humans but not a phase 1? Perhaps they want to complete the early phase trial first? Perhaps they don’t want to approve a trial for 88 volunteers for phase 1?

    I think this may be a slight over reaction once details are clarified. This could be a minor amendment or it could be a catastrophe

    the biggest disgrace is managements handling of the situation.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
0.002(5.71%)
Mkt cap ! $5.350M
Open High Low Value Volume
3.7¢ 3.7¢ 3.7¢ $555 15K

Buyers (Bids)

No. Vol. Price($)
2 27600 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 30917 1
View Market Depth
Last trade - 14.38pm 01/11/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.